FDA Adverse Event
Injury
Summary report: N
REPLACEMENT KNEE
MDR report key: 15210048
·
Received August 10, 2022
Report
- Report Number
- MW5111413
- Event Type
- Injury
- Date Received
- August 10, 2022
- Date of Event
- June 15, 2022
- Report Date
- August 8, 2022
- Manufacturer
- NOVOSOURCE, LLC.
- Product Code
- JWH
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- WV, US
- Reporter Occupation
- PATIENT
- Health Professional
- *
Narratives
Description of Event or Problem · 0
I HAD A TOTAL KNEE REPLACEMENT ON "(B)(6) 2021" HAVE HAD SWELLING AND SEVERE PAIN. ON (B)(6) 2022 I WENT TO MY SURGEON AND HE DID X-RAYS, AND BLOOD WORK SAID EVERYTHING WAS FINE. THEN I WENT BACK TO HIM AGAIN (B)(6) 2022 AND HE DRAINED FLUID OFF MY KNEE AND ORDERED A BONE SCAN FOR (B)(6) 2022 I WAITED UNTIL MY NEXT APPOINTMENT WITH HIM ON (B)(6) 2022 HE THEN TOLD ME THAT MY KNEE WAS LOOSE AND I WOULD HAVE TO HAVE REVISION SURGERY. MY HUSBAND ASKED HIM WHAT ABOUT IF THIS DOESN'T WORK HE THEN SAID HE WOULD JUST HAVE TO AMPUTATE ABOVE THE KNEE. FDA SAFETY REPORT ID# (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1941618 | REPLACEMENT KNEE | PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL | JWH | NOVOSOURCE, LLC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 56 YR | Female | Other| R| S | AMLODIPINE/BENAZEPRIL5-40 MG 1 TABLET PER DAY| ESCITALOPRAM 20 MG 1 TABLET PER DAY| FUROSEMIDE 40 MG 1 TABLET PER DAY| LORAZEPAM 2 MG 1 TABLET X 2 PER DAY| LOW DOSE ASPIRIN 80 MG 1 TABLET PER DAY| NAPROXEN 500 MG 1 TABLET 2X PER DAY | PERSERVISION ARED 2VITAMINS 1 TABLET 2X PER DAY| QUETINPINE 50 MG 1 TABLET PER DAY |